Understanding supplements.
How do I evaluate what I'm actually buying — in the hormone-balance market?
The PCOS aisle is the women's-health supplement industry at its most aggressive — a market that historically sold 'hormone balance' blends of unlisted doses before the evidence era arrived and mostly ignored it. Evaluation here means knowing what a real trial-backed product looks like: inositol at the studied 4 g / 40:1 pattern, standardized berberine with the interaction conversation attached, and clean omega-3 — versus the 'PCOS complexes' that stack spearmint, inositol at 500 mg, and fairy dust under a rose-colored label. The dose is the product; the ratio is the claim.
Powders
Inositol — the honest dose format
Capsules
Berberine, standardized
Softgels
Omega-3 — count EPA+DHA
Gummies
The dose ceiling problem — see below
Myo 4 g + D-Chiro 100 mg (40:1) — or Pure Myo
The trial material: gram-dose myo-inositol, optionally with D-chiro at the ovary's physiologic 40:1 ratio. Powders exist because 4 grams means 8+ capsules — the honest format. Mild GI at initiation, taken in water across the day or split morning/evening.
High-D-Chiro & 'PCOS Blends'
D-chiro-dominant formulas invert the ovary's own ratio — theoretically ovarian-suppressive in sustained high doses — and 500 mg 'complexes' contain an eighth of the tested material. The label math is the entire evaluation: doses and ratio, or nothing.
Choosing the Right Form & Dose
Label literacy in the PCOS aisle has three specific jobs:
- Inositol math: 4 g myo + 100 mg D-chiro (40:1), or gram-dose pure myo — check grams per serving, not 'mg of blend'; the dose IS the product.
- Berberine standardization and the conversation: 500 mg HCl, split dosing — and the physician call BEFORE the purchase in this prescription-heavy population.
- Omega-3 counting: EPA+DHA per serving with a fat-containing meal — the library-wide rule, ovary edition.
- The standing rule: fertility plans route every bottle through the preconception review — this aisle's highest-stakes instruction.
Red Flags to Watch For
The hormone-balance market sells hardest to this population. Be highly cautious of products that:
- Sell 'hormone balance' proprietary blends — vitex, maca, dong quai stacks with unlisted doses in a condition defined by hormonal measurement: unstandardized inputs to a calibrated system.
- Cite inositol trials on 500 mg blends — the tested dose was 4 g; an eighth of the material is not a gentler version, it's a different product borrowing better research.
- Market 'fertility support' implying treatment — letrozole exists precisely because PCOS infertility is very treatable medically; a blend implying substitution is selling delay.
- Lack third-party verification (USP, NSF, ConsumerLab, IFOS) — with hormonal conditions and preconception stakes, label accuracy is the floor.